Understanding how Pseudomonas aeruginosa survives in the presence of nitric oxide.

Uncovering mechanisms of nitric oxide detoxification and reactivity in Pseudomonas aeruginosa

NIH-funded research Rutgers, the State Univ of N.j. · NIH-10866077

This study is looking at how a germ called Pseudomonas aeruginosa, which can cause serious infections, survives when your body's immune system tries to fight it off using a substance called nitric oxide; by understanding how this germ protects itself, researchers hope to find new ways to treat infections, especially those that are hard to treat with antibiotics.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRutgers, the State Univ of N.j. NIH-funded
Lab location1 site (Piscataway, United States)
Project IDNIH-10866077 on NIH RePORTER

What this research studies

This research investigates how the bacterium Pseudomonas aeruginosa, a common cause of serious infections, manages to survive despite the host's immune response that produces nitric oxide (NO) to eliminate it. The study focuses on the mechanisms of nitric oxide detoxification and reactivity within the bacteria, exploring how it interacts with the immune system and the environment. By examining genetic mutants of P. aeruginosa, researchers aim to identify specific pathways that allow the bacteria to resist the effects of NO, which could lead to new therapeutic strategies. The findings may provide insights into the development of treatments for infections caused by antibiotic-resistant bacteria.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients with chronic infections caused by Pseudomonas aeruginosa, particularly those who are immunocompromised or have antibiotic-resistant infections.

Not a fit: Patients with infections caused by other types of bacteria or those who are not immunocompromised may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options for patients suffering from infections caused by antibiotic-resistant Pseudomonas aeruginosa.

How similar studies have performed: Other research has shown success in understanding bacterial resistance mechanisms, making this approach promising but still requiring further exploration.

Where this research is happening

Piscataway, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.